Auditory evoked potentials (AEP) were used to monitor central nervous system effects during induction and recovery from anaesthesia produced by infusion of propofol 30 mg kg -1 h -1 in 22 healthy male patients. Non-parametric and parametric modelling techniques were used successfully to calculate the parameter k eo which linked pharmacokinetic with pharmacodynamic aspects of drug action in only 15 of the study patients. In the non-parametric analysis, k eo was found to have a mean value of 0.2 (range 0.1-0.36) min -1 . Estimation of k eo allowed calculation of the effect-site concentration (Ce 50 ) associated with 50% of AEP effect for the population (2.08 µg ml -1 ; 95% confidence limits 1.7-2.45). There were no significant differences between k eo values calculated by non-parametric and individual parametric modelling techniques. During recovery, 50% of patients demonstrated evidence of waking at an effect-site concentration of 2.28 µg ml -1 .
The rational use of i.v. agents for induction and maintenance of anaesthesia requires an appreciation of both the pharmacokinetics and pharmacodynamics of the agent in use. Pharmacodynamic aspects of drug action can be linked to pharmacokinetic behaviour by extending a pharmacokinetic model to include a further 'effect' compartment. 1 2 The only additional parameter required to describe drug behaviour in such a compartment is the parameter 'k eo ' which determines the equilibrium delay between the central compartment of the pharmacokinetic model and the effect compartment. Estimation of k eo for a given drug allows calculation of the effect-site concentration (Ce) of the drug which has a much closer relationship in non-equilibrium situations to the intensity of drug effect than blood concentration (C P ), as blood is not the site of anaesthetic drug effect.
In this study, we have used auditory evoked potentials (AEP) 3 to measure central nervous system (CNS) effects during infusion and recovery from propofol, with the objective of determining the value of k eo for propofol in healthy male patients. Knowledge of the k eo for propofol makes it possible to describe the relationship between observed AEP effect and effect-site concentration. We have compared a non-parametric analysis with a parametric analysis so that the values of k eo derived in an analytically correct manner (but which has minimal practical or clinical use) are compared with those derived in an analytically © British Journal of Anaesthesia less ideal manner (but which facilitates simulations and predictions of relevance and value to clinical practice). We have calculated, where possible, values of k eo for each individual, together with pooled data estimates for the study population. Calculation of k eo in each instance allowed estimation of that effect-site concentration (Ce 50 ) at which 50% of the maximal effect was observed.
Patients and methods
After obtaining approval from our institute and informed consent, we studied 22 healthy (ASA I), unpremedicated, male patients undergoing elective general surgical or orthopaedic procedures. Mean age was 32.7 (range 19-51) yr and mean weight 83.4 (SD 10.6) kg. Exclusion criteria were concomitant medication, excessive alcohol intake (Ͼ 4 units daily), drug abuse, mental retardation, psychiatric disturbance and subjective hearing impairment.
Before induction of anaesthesia, a 20-gauge radial arterial catheter was inserted under local anaesthesia to provide continuous haemodynamic monitoring. Arterial blood samples were obtained at 1-min intervals throughout the study. An i.v. 19-gauge catheter was inserted into a forearm vein on the contralateral side to the arterial line and was connected to an infusion system. A one-way valve was inserted at the site of the propofol administration system to prevent retrograde flow of the drug. Additional routine anaesthesia monitoring comprised continuous ECG monitoring, end-tidal capnography and pulse oximetry. The AEP monitor used, together with details concerning signal acquisition and AEP analysis, have been described elsewhere. [4] [5] [6] The intensity of CNS effect was measured by the AEP index calculated by the AEP system. AEP index is a mathematical derivative which reflects AEP waveform morphology. 7 8 A baseline AEP index was obtained during a 5-min period before induction of anaesthesia with the patient lying quietly with the eyes closed and breathing 100% oxygen via a face mask. When suitable baseline conditions had been achieved, a zero-order propofol infusion (30 mg kg -1 h -1 ) delivered by a Graseby 3400 infusion pump (Graseby Medical Ltd, Watford, UK) was commenced and continued until the patient was deemed clinically anaesthetized and the AEP index was unchanged over 3 consecutive minutes. Recovery from propofol infusion was thereafter monitored until the AEP index indicated impending patient arousal (AER index greater than 80% of baseline value) whereupon anaesthesia was subsequently deepened in preparation for surgery. The record of AEP index vs time for each patient was stored on computer disk for subsequent analysis.
Propofol assays
Blood sampling and propofol assays were performed as described by Vuyk and colleagues. 9 Sample volume was 5 ml and samples were stored at 0-4°C. Arterial blood samples were obtained within 10 s at 1-min intervals until each individual showed signs of emergence (duration of sampling period mean 20.2 (range 12-30) min). The coefficient of variation was ഛ7% in the concentration range encountered in the study and the lowest limit of detection was 5 ng ml -1 . The inter-batch coefficient of variation was 5%.
Pharmacokinetic-pharmacodynamic analysis
Calculation of Ce was performed in two stages. 2 First, the blood concentration-time response to the drug input regimen was determined and, thereafter, effect-site concentrations were calculated on the basis of the blood concentrationtime relationship for an optimized estimate of k eo . Two different analytical approaches were used in the first stage of this process: (1) parametric and (2) non-parametric.
A parametric estimation implies that effect-site concentrations of drug are calculated on the basis of plasma concentrations predicted by a given parametric pharmacokinetic model. Such parametric models have the advantage that each is described concisely by the model parameters. Such a model has a general utility in that the mathematical rules that govern the operation of the model can be combined with the model parameters to make predictions about the concentration-time relationship after a specified dose scheme. However, when used analytically, such models constrain against the fitting of the predicted blood concentration-time curve to the observed data and this can lead to inappropriately based calculations of effect-site concentrations when such fitting is poor. 10 A non-parametric model has no predictive utility but is, nevertheless, analytically attractive because no assumptions are made regarding the physiological or pharmacokinetic nature of the model. The only assumption made is that the central compartment of an otherwise undefined pharmacokinetic model is linked to the effect-site by a first-order rate constant and that clearance of the drug from this effect compartment is also a first-order process (Fig. 1) . Effectsite concentrations are calculated solely on the basis of the observed arterial concentrations of drug and no fitting procedure is involved. In a non-parametric analysis, subsequent determination of k eo is then more accurately described as 'semi-parametric' rather than 'non-parametric' as first rate order processes are assumed in the link between the pharmacokinetic model and the postulated effect compartment. Nevertheless, for the purposes of this article, we retain, where appropriate, the term 'non-parametric'.
Computer analysis
Best fit individual pharmacokinetic models for the observed arterial concentrations of propofol were derived by PKOPT, a computer program written by one of the authors (M. W.). This program was written in GFABasic for Windows v37 (GFA Data Media (UK) Ltd) and runs in compiled form on an IBM Pentium PC under Windows95 (Microsoft Corporation). The program uses non-linear regression to minimize the extended least squares objective function (NONMEM objective function (-2 log likelihood (-2LL)). 11 12 Data input for this program is completely automated and consists of pre-formatted files with details of measured propofol concentrations together with corresponding sampling times and details of the infusion administered to each patient. Population pharmacokinetic modelling was performed with the program NONMEM 11 (University of California (San Francisco) version (IV); level (2.1)). k eo values for each individual in the study were estimated (a) parametrically (on the basis of best individual parametric fit) and (b) non-parametrically, both by the program (K eo estimator). This program is based on that described by Fuseau and Sheiner 13 and was also written by one of the authors (M. W.) in GFABasic for Windows. The program uses as automated input the propofol concentration data used by PKOPT together with the AEP index record file. The program estimates k eo by iterating its value and selecting that value of k eo at which hysteresis between the induction and recovery phases of the AEP index and effect site concentration (Ce) relationship is minimized. 13 Sigmoid E max curves were fitted from effect% vs effectsite concentration curves using WINNONLIN version 1.1 (1996) (Scientific Consulting Inc.,Cary, NC, USA).
Effect% was calculated from the formula:
Baseline AER index-observed AER index
Baseline AER index-AER index at maximum effect ϫ 100
Statview for Windows (version 4.5) (1996) (Abacus Concepts Inc., Berkely, CA, USA) was used for statistical analyses. Probability values less than 0.05 were considered significant. Figure 2 shows the relationship between arterial blood propofol concentration and AEP index in a representative patient. For the non-parametric approach, the observed arterial concentrations of propofol were used directly to calculate Ce on the basis of a given estimate of k eo , whereas for the parametric approach, the PKOPT program was used to derive the best fit two-compartment pharmacokinetic model for each individual and the model predictions of blood propofol concentrations were used to calculate Ce. The program NONMEM was used to calculate the estimates of a two-compartment population pharmacokinetic model for all 22 individuals in the study group on the basis of pooled data (Table 1) . Both PKOPT and NONMEM failed to demonstrate any significant reduction in the respective objective functions when open three-compartment, rather than two-compartment, modelling was used. For each of the three approaches, the relationship between Ce and effect (as determined by AEP index) for a given value of k eo could then be determined for the course of the experiment. For both the non-parametric and the two parametric methods (individual and population), the value of k eo was iterated by the computer program (K eo estimator) to determine the value at which hysteresis between the two limbs representing the induction and recovery phases of the experiment was minimized. Figure 3A , B and C demonstrate the time response of AER index during and after infusion of propofol. For seven patients in the study, the program was unable to estimate k eo . In these cases, the record of AEP index either did not demonstrate a progressive increase in the value of AEP index during the recovery phase of the experiment but rather a flat response followed by a sudden increase only as the patient's clinical level of arousal increased (five patients) (Fig. 3B) or, alternately, demonstrated unexplained periods of excitation during the experiment (two patients) (Fig. 3C ). These patterns of response produced a Ce vs effect relationship which could not be efficiently minimized within the constraints set by the k eo estimator program 13 and therefore for each of these individuals a corresponding value of k eo could not be calculated. Hysteresis between the induction and recovery limbs of the effect-Ce relationship was minimized at optimum k eo . The optimum k eo values calculated by the non-parametric and the individual and parametric analyses for those patients whose hysteresis curves were successfully collapsed are shown in Figure 4A shows individual sigmoid E max curves fitted by WINNONLIN from each individual's optimally collapsed hysteresis curve. In Figure 4B , a population sigmoid E max was constructed by fitting a curve to the pooled effect%-Ce data for all those patients for whom hysteresis could be successfully collapsed. Similar population sigmoid E max curves were constructed from the effect%-Ce data derived using both the individual parametric and population parametric approaches (Fig. 4C) .
Results
Estimates of Ce 50 and γ for these three curves are tabulated in Table 3 . The calculated effect-site concentration at which each individual began to demonstrate early clinical signs of arousal (movement or phonation) after termination of propofol infusion was noted and the percentage of aroused patients was plotted vs effect-site concentration (Fig. 5 ): a reversed sigmoid E max curve was then fitted to the data. The EC 50 for arousal was estimated to be 2.28 µg ml -1 (95% confidence limits 2.2-2.36; γϭ5.62).
Discussion
We have used auditory evoked potentials as the determinant of the effect of propofol on the central nervous system in order to determine the parameter (k eo ) that dynamically characterizes the effect compartment for the drug in healthy male patients. The sets of k eo values obtained when either non-parametric or individual parametric modelling techniques were used were not significantly different. However, there was a significant difference between the k eo values calculated using the population parametric analysis compared with those obtained using the non-parametric analytical method. In these circumstances, the constraint of using population kinetic parameters to estimate blood concentrations of propofol and applying these parameters to individuals who are less representative of the population results in the calculation of k eo values which differ from those calculated by the non-parametric method. Furthermore, the duration of sampling used in the study was relatively short (12-30 min) in relation to the terminal half-life of the model and this may also give rise to some inaccuracy in the estimation of the population model parameters. The mean value of k eo obtained by the non-parametric method for the study group was 0.20 min -1 . Hitherto, the only published k eo for propofol is that reported in a congress abstract by Schuttler, Schwilden and Stoeckel 16 (mean T1 2 (k eo )ϭ2.9 min: mean value k eo ϭ0.24 min -1 ) in a group of six healthy male volunteers when EEG median frequency was used to determine the effect of propofol on the central nervous system and when parametric modelling techniques were used. We found that the range of estimated k eo (using the non-parametric method) within our study group was considerable, varying between 0.1 and 0.36 min -1 . This Fig 4 A: Individual sigmoid E max curves derived from non-parametrically derived effect%-Ce curves at optimized (minimal hysteresis) k eo . B: Pooled data sigmoid E max curve (thicker line) derived from non-parametrically derived effect%-Ce curves. The thick line is superimposed on the optimally collapsed hysteresis curves (thinner lines) for each of the individuals in the study group for whom such collapse was achieved successfully. C: Pooled data sigmoid E max curves derived from non-parametric, individual parametric and population parametric (thin). variability in k eo could not be ascribed purely to interpatient pharmacokinetic variability as use of both nonparametric and individualized parametric modelling techniques removed this factor from the overall modelling process.
There is currently much interest in the use of auditory evoked potentials as a monitor of anaesthetic depth. The technique has the theoretical advantage that it derives its signal from a single neurological pathway in contrast with 337 unprocessed EEG which derives it signal from global central nervous system activity. A wide range of both inhalation and i.v. anaesthetic agents produce similar changes in the early cortical waves of the AEP signal. Furthermore, the AEP signal obtained during surgery appears to represent a balance between CNS depression caused by anaesthetic drugs and activation induced by noxious stimuli. 3 Our study was performed in the total absence of noxious stimuli caused either by anaesthetist or surgeon. Under these circumstances, it was presumed that the changes in the AEP signal would be related directly to predicted concentration of drug in the brain. In each of the study patients, the AEP index decreased in a progressive manner after commencement of the propofol infusion until E max was reached. However, in seven of 22 patients, it proved impossible to calculate a value of k eo for the individual owing to the fact that it was not possible to collapse the hysteresis curve in an acceptable manner. In these individuals the inability to collapse the hysteresis curve was caused either by unexplained excitation during the experiment or by a flat response of the AEP index vs predicted Ce curve during the late stages of the recovery curve. In these latter instances, the AEP index returned to awake levels only when the patient had already began to demonstrate clinical signs of arousal. It appeared that, in these individuals, the process of awakening from propofol-induced anaesthesia was associated with an 'on-off' AEP index response rather than a gradual progression to awake levels. The observed data in these seven patients suggest that the proposed effect model was not applicable to all patients in the study. Doi and colleagues 5 reported that during emergence from anaesthesia, the AEP index before eye opening correlated poorly with predicted blood propofol concentrations, whereas bispectral index and 95% spectral edge frequencies both correlated well with predicted blood concentrations of propofol. However, AEP index was demonstrated as being superior to EEG methods in distinguishing the conscious from the unconscious state. It may be that the pharmacodynamics of propofol may differ according to the monitoring technique used. AER, bispectral index and spectral edge frequency all require similar time periods (approximately 30 s) for complete update of their signal.
In our study, the mean value of Ce 50 was 2.08 µg ml -1 (95% confidence limits 1.7-2.45) using the pooled data from the non-parametric modelling analysis. It is of interest to relate these values to clinical end-points. Forrest and colleagues 17 reported that, in an unpremedicated population of patients, an equilibrated blood propofol concentration of 3.1 (2.7-3.5) µg ml -1 was necessary to suppress 50% of maximum EEG median power frequency in the absence of external stimulation which implies that the AER index is more sensitive to the effects of propofol than unprocessed EEG. In the same study, it was found that, under steady state conditions, mean EC 50 and EC 95 values for loss of consciousness were 2.3 µg ml -1 and 3.1 µg ml -1 (where EC 50 and EC 95 are defined as those equilibrated blood concentrations of propofol at which 50% and 95%, respectively, of the study population lost consciousness) . In a similar study using only clinical end-points, Vuyk and colleagues 9 reported that the EC 50 and EC 90 values of propofol for loss of eyelid reflex in a group of 18 young female patients were 1.85 and 2.69 µg ml -1 whereas the corresponding values for loss of consciousness were 3.34 and 4.17 µg ml -1 . Smith and colleagues 18 reported that the EC 50 (Cp 50 in their terminology) and EC 95 (Cp 95 ) at which their study patients lost response to verbal command were, respectively, 3.3 and 5.4 µg ml -1 . In a more recent study of Japanese subjects, Kazama, Ikeda and Morita 19 found higher values for EC 50 and EC 95 for loss of consciousness (4.4 and 7.8 µg ml -1 ). The reason for the differences in the EC 50 and EC 95 values obtained in these studies is unclear. It may be that the level of the stimulus applied varied between studies, that the equilibration times were inadequate in some of the study patients, or that there are racial or cultural reasons for the observed differences.
To avoid confusion in terminology, it should be borne in mind that EC 50 and Ce 50 are not equivalent and cannot be used in an interchangeable manner. EC 50 (or Cp 50 ) is that equilibrated plasma concentration at which 50% of individuals have reached a given non-continuous end-point (e.g. eye closure or loss of consciousness), whereas Ce 50 denotes that effect-compartment concentration at which an individual or a 'population-individual' displays 50% of the recorded maximum effect. Figure 6 demonstrates this point. The EC 50 at which 50% of patients started to show clinical evidence of arousal was 2.28 µg ml -1 whereas the Ce 50 at which 50% of maximum suppression of AEP effect occurred was 2.08 µg ml -1 .
Knowledge of the k eo value of a drug provides insight into its clinical use which is not apparent from pharmacokinetic modelling concepts alone. First, equilibration of the effect- site concentration with steady state blood concentrations takes 4-5 times T 1/2 (k eo ) (where T 1/2 (k eo )ϭ0.693/k eo ). Thus if we were to request a certain blood concentration using a target controlled (TCI) delivery system, 20 21 then we can predict that it would take approximately 15 min for equilibration between the effect and central compartments to occur if k eo is taken to be 0.20 min -1 . We have calculated a range of k eo values between 0.1 and 0.36 min -1 for our patients. These results suggest that some studies which were designed to permit equilibration between blood and effect compartments did not allow adequate time for this process to occur in all patients since if the k eo for a given individual is 0.1 min -1 then the time taken for equilibration between blood and the effect compartment is approximately 28 min.
In order to achieve a given effect-site concentration in a shorter time, then the concept of overpressure (familiar from inhalation anaesthesia) can be used to force drug into the effect compartment at a faster rate, whereby a much higher blood concentration is initially achieved than the desired effect concentration. The mean value of k eo of 0.20 min -1 derived in this study for propofol is substantially less than that of 0.58 min -1 derived for thiopental. 22 This implies that propofol is taken up into the effect compartment less rapidly than that of thiopental and explains why propofol is a clinically less appropriate induction agent compared with thiopental when rapid intubation to secure the airway is the priority.
We have calculated k eo values for propofol using a nonparametric method but have demonstrated that the values obtained by a parametric method were similar. We have demonstrated that the values of k eo thus obtained can be used in the context of a parametric model and that subsequently the values obtained have use with respect to pharmacokinetic model-based simulations. It is important to note that the estimated value of k eo that correlates observed pharmacodynamics with pharmacokinetics varies according to the performance of a particular pharmacokinetic model in predicting experimentally observed blood concentrations of propofol and that the value of k eo used in a simulation cannot be used in association with a pharmacokinetic model other than that which was used in its estimation.
The concept of the effect compartment, particularly when applied to anaesthetic and analgesic drugs, is especially useful because it allows the anaesthetist to relate drug dose to drug effect in a more sophisticated manner than is otherwise possible by consideration of blood concentrations alone, as such a concept provides an appreciation of the delays involved for equilibration between clinical effect and blood concentration. In our study, we reported the estimated values of k eo for propofol in 15 of 22 healthy male patients and, on the basis of these values, described the relationship between AEP index and effect-site concentration of propofol. For the remaining seven patients, an individual value of k eo could not be estimated.
